
Horizon Discovery hires non-executive director
pharmafile | August 5, 2013 | Appointment | Manufacturing and Production, Research and Development, Sales and Marketing | Gilham, Horizon Discovery
Research tools firm Horizon Discovery has announced the appointment of Dr Ian Gilham as a non-executive director.
Gilham is currently non-executive chairman of Multiplicom NV, focussed on the development and commercialisation of DNA sequencing products; and Biosurfit SA, focused on development and commercialisation of point-of-care diagnostic products.
He is also director of Stowheath, which offers advisory services to private equity companies and corporate finance organisations investing in clinical diagnostics and medical device companies. Gilham has previously been chief executive of Axis-Shield and vice president, Pharmacogenetics and Diagnostics at GSK, as well as holding various positions within Abbott Laboratories.
Dr Darrin Disley, chief executive of Horizon said: “I would like to welcome Ian to Horizon’s board of directors. His commercial and investor relations experience will be highly valuable to the company as we continue to develop as a world-leading translational genomics organisation.”
Gilham added: “Horizon is one of the UK’s most promising life science companies. I’m delighted to join the board at this stage of the organisation’s development.”
Related Content

Horizon and Fulcrum Therapeutics form CRISPR collaboration
Horizon Discovery has announced that it has entered into a partnership with Fulcrum Therapeutics to …
Horizon forms new cancer advisory board
UK biotech Horizon Discovery has formed a new Scientific Advisory Board (SAB) for its diagnostics …






